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Influence of peak expiratory flow monitoring on an
asthma self-management education programme
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Spain
We assessed whether peak expiratory flow monitoring added to a self-management education programme reduced
morbidity and improved pulmonary function and adherence to treatment in 100 asthma patients (aged 17–65 years)
with adequate treatment and regular 1-year follow-up. Patients randomized to the experimental group used peak
expiratory flow readings as the basis for their therapeutic plan coupled with educational intervention, whereas
patients in the control group received the same educational intervention and used symptoms only to guide self-
management. Morbidity parameters, functional status and adherence to medical regimens improved in both
groups, although the percentage of patients with satisfactory adherence was significantly better in the group with
peak expiratory flow monitoring (83%) than in controls (52%) (P=0.05). The multivariate analysis showed that
severity of asthma (odds ratio 9.28, 95% confidence interval 1.87–45.96, P= 0.006 for moderate asthma) and type
of self-management education programme (odds ratio: 6.19; 95% confidence interval: 2.04–18.81; P= 0.001 for the
use of peak expiratory flow readings) were the only independent predictors of adherence to treatment. However, a
statistically significant association between adherence and use of peak expiratory flow monitoring was only found
in patients with moderate asthma (P= 0.0009). We conclude that peak expiratory flow monitorization in optimal
conditions (adequate medical regimen, individualized self-management education and regular follow-up) showed a
beneficial eect on adherence to prescribed regimens only in patients with moderate asthma.
Key words: asthma; self-management education programme; peak expiratory flow; adherence to treatment;
pulmonary function tests; morbidity parameters.
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According to guidelines on asthma management, patient
education is thought to be essential in the treatment of
adult asthma (1–7). Great emphasis is placed on educating
asthmatics to improve asthma knowledge, promote adher-
ence to treatment and improve health outcomes. Limited
(information only) patient education programmes have
shown a modest impact on morbidity (8), whereas
improvement in asthma control and reduction in the use
of healthcare facilities can be attained by programmes that
integrate instruction, written self-management plans and
regular follow-up (9). However, several unknowns remain
regarding the essential components of asthma education
programmes and it is not clear whether self-management
programmes based on clinical symptoms are similar to
those using peak expiratory flow monitoring (10–19).
Although the routine use of peak flow meters to guideReceived 4 October 1999 and accepted on received from 17
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0954-6111/00/080760+07 $35?00/0interventions is not the only way of improving asthma
control, it seems that among patients with higher risk of
severe asthma attacks and poor self-perception of symp-
toms, the benefits obtained from a self-management
programme based on peak flow monitoring may be greater
than those obtained from a self-management programme
based on symptoms only (7,20,21). Peak flow readings have
been recommended for early recognition of changes, to be
able to adjust treatment accordingly and to reinforce
adherence to prescribed regimens (10,22). In conjunction
with self-management programmes, treatment of asthma
should be periodically reviewed and optimized (23).
This prospective randomized study was conducted to
assess whether peak expiratory flow monitoring added to a
self-management education programme reduced morbidity
and improved functional status and adherence to the
prescribed regimen in asthma patients with adequate
treatment and regular follow-up.
Patients and methods
All consecutive patients who required treatment in an
emergency department of acute-care hospitals in the area of
Gijo´n, Asturias (Spain) over an 18-month period because of# 2000 HARCOURT PUBLISHERS LTD
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Inclusion criteria were as follows: 17–65 years of age,
symptomatic disease during the previous year and volun-
tary participation in the study. Each patient satisfied the
American Thoracic Society (ATS) definition of asthma,
with symptoms of episodic wheezing, cough and shortness
of breath responding to bronchodilators, and reversible
airflow obstruction documented on at least one previous
pulmonary function study (24). Reversibility was defined as
a 420% increase in the forced expiratory volume in 1 sec
(FEV1) or peak expiratory flow following inhalation of
salbutamol (0.2mg) (25). In patients with normal spiro-
metric data at the initial assessment (before randomization)
and lack of functional demonstration of asthma before
their visit to the emergency department, a methacholine
challenge test was required. The challenge was terminated
when FEV1 fell by more than 20% from baseline value
(PD20). Patients with concurrent chronic diseases that may
aect the interpretation of results (COPD, emphysema,
cystic fibrosis, severe rheumatoid arthritis, neoplasia, etc.)
were excluded. Those patients who agreed, signed the
written informed consent and were studied for 12 months.
Patients were randomly allocated into an experimental
group or control group.
Initial assessment was carried out approximately 1
month after discharge from the emergency department
and included a complete medical history; physical exam-
ination; spirometry to measure forced vital capacity (FVC),
FEV1 and FEV1/FVC; instructions for measuring correctly
the peak expiratory flow rate (PEFR) with a Mini-Wright
peak-flow meter (Clement-Clarke International Ltd., Essex,
U.K.); and evaluation of morbidity parameters. Forced
vital capacity manoeuveres were performed using a dry
wedge spirometer (Vitalograph, Vitalograph Ltd., U.K.),
the best of three readings being used for analysis. Adequacy
of the inhaler technique was determined by a seven-point
inhaler-use checklist developed by Manzella et al. (26) and
defined as correct (when all steps were satisfactory) orTABLE 1. Questionnaire for assessing adherence to medication
Medication and inhaler adherence scale
A. During the last 3 months, have you at times been careless ab
or nebulizer?
B. During the last 3 months, have you ever forgotten to take
because you felt better?
C. During the last 3 months, have you ever stopped taking
because you felt better?
D. During the last 3 months, have you ever taken less of your b
the doctor prescribed because you felt better?
E. During the last 3 months, have you ever stopped taking
because you felt worse?
F. During the last 3 months, have you ever taken more of you
than the doctors prescribed because you felt you were having b
Adherence was defined as satisfactory when answers to all item
Adherence was defined as poor when answers to one or more iincorrect. A questionnaire was used to collect information
on asthma-related morbidity at each visit and included days
with symptoms (cough, wheezing, shortness of breath) (51
vs.  1 days per week) and sleep disruptions (51 vs.  1
days per week) in the previous 3 months; frequency of
asthma attacks (none vs. one or more) in the previous 3
months; and number of visits to the emergency room,
number of hospital admissions and full days lost from work
or school (none vs. one or more) in the previous 12 months.
Morbidity was reported as low and medium to high
according to the morbidity index described by Jones et al.
(27) based on three questions: are you in a wheezy or
asthmatic condition at least once per week; have you had
time o work or school in the past year because of your
asthma; do you suer from attacks of wheezing during the
night? (all answers negativelow morbidity; one armati-
vemedium; two or three armativehigh).
Medical regimens were tailored to each patient’s asthma
pattern (1) and included the administration of inhaled b-
agonists when needed in mild asthma; inhaled salbutamol
0.2 mg or terbutaline 0.5mg and budesonide 400 mg every
12 h in moderate-severe asthma with FEV180% of the
predicted value; and inhaled salbutamol 0.2mg or terbuta-
line 0.5mg every 8 h or when needed, budesonide 800 mg
every 8 h, and prednisone 40mg day71 (maximum 1mg
kg71 day71) for 14 days in moderate–severe asthma with
FEV1 580% of the predicted value. After the initial 14
days of treatment, no patient continued to use short-acting
b-agonists uninterruptedly. Adherence to the prescribed
regimen was assessed by the medication adherence scale
and the inhaler adherence scale reported by Dolce et al. (28)
combined in a single six-item questionnaire as shown in
Table 1. Since a Spanish translation of this instrument has
not been validated, instead of using the sum of ‘no’
responses for the adherence measure scores as in the study
of Dolce et al. (28), adherence was simply defined as
satisfactory when responses to all items were ‘no’ or poor
when one or more of the responses was ‘yes’.out taking your breathing medications including your inhaler
your breathing medicine or to use your inhaler or nebulizer
your breathing medicine or using your inhaler or nebulizer
reathing medicine or used your inhaler or nebulizer less than
your breathing medicine or using your inhaler or nebulizer
r breathing medicine or used your inhaler or nebulizer more
reathing problems?
s were ‘no’.
tems was ‘yes’.
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instruction on general concepts and management of asthma
(e.g., chronic disease, dierence between inflammation and
bronchoconstriction, clinical manifestations, mechanism of
action of anti-asthmatic drugs, need to take medication
daily, adverse eects, etc.) and were taught by a nurse to
acquire skills in self-management (Table 2). Patients also
received a self-management plan with a card of colour-
codes and diary cards, modified from Charlton et al. (15)
(with top marks at 80%, 60% and 40% of the best patient’s
value) in which symptoms, medication and PEFR values
had to be registered. Patients in the control group received
the same education programme except for informative
pamphlets; dairy cards for symptoms, medication and
PERF; and self-management plan with a card of colour-
codes. The education programme included adherence-
enhancing strategies for all patients.
Follow-up visits were scheduled at 15 days, 1 month and
every 3 months thereafter until the end of the study.
Information and training on proper use of inhalers and
acquisition of skills in self-management were gradually
instituted during the first three visits. One physician was
responsible for the assessment of all patients’ conditions
and modifications of treatment and a nurse for reinforce-
ment of asthma self-management education at follow-up
visits. Treatment was adjusted according to symptoms,
spirometric data and variability of PEFR in patients in the
experimental group. In the control group, treatment was
adjusted according to symptoms reported by the patient
and results of spirometry, which was performed on the day
of the follow-up visit. Daily variability of peak expiratory
flow was calculated with the formula: best PEFR7worst
PEFR/mean %, with mean readings for a period of 14
days. Less than 10% variability was considered irrelevant
for the purpose of adjustment of treatment. At the 12-
month follow-up visit, spirometry was again performed andTABLE 2. Asthma education programme
Content
1. General concepts of asthma and its treatment
2. Idem with informative pamphlets
3. Instructions to acquire skills in self-management
4. Recognition of provoking factors and how to avoid them
5. Idem with pamphlet about environmental measures
6. Diary cards for symptoms, medication, and PERF
7. Self-management plan with a card of color-codes
8. Self-management plan based on symptoms only
9. Adherence-enhancing strategies
Interrelation and communication with the patient
Simple written therapeutic plan tailored to each patient
Information on adverse aects and how to prevent them
Assessment of expectations and therapeutic aims
Techniques to prevent forgetting medication
Assessment of adherence at each visit
Discussion of adherence problemsinhaler technique, morbidity parameters and adherence to
treatment were checked.
STATISTICAL ANALYSIS
Data from the experimental and control groups collected at
baseline and 12 months after intervention were assessed for
normal distribution with the Kolmogorov–Smirnov test
and compared using the Student’s t-test or the Mann-
Whitney U-test for independent groups, the paired t-test or
the Wilcoxon’s test for paired data, and the w2-test or the
MacNemar’s test for categorical data. Independent pre-
dictors of adherence to an anti-asthmatic regimen were
determined by means of a logistic regression model in which
adherence was the dependent variable and morbidity
(dichotomized as low vs. medium to high), improvement
in morbidity (dichotomized as from the first visit to the end
of the study vs. no improvement), type of intervention
(experimental vs. control group) and severity of asthma at
baseline (1) were the independent variables. Statistical tests
were two-tailed.
Results
Of 192 consecutive patients requiring treatment in an
emergency department for asthma symptoms, 150 (78%)
were enrolled in the study. The remaining 42 patients were
not recruited because symptoms were caused by respiratory
disorders other than asthma (n23), lack of definite
diagnosis of asthma (n14) and refusal to participate in
the study (n 5).
Of the 150 patients enrolled in the study, 100 patients (56
in the experimental group and 44 in the control group)
completed the 12-month follow-up period. There were no
statistically significant dierences in age, sex and severity ofExperimental group Control group
X X
X
X X
X X
X
X
X
X
X X
X X
X X
X X
X X
X X
X X
X X
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follow-up period and those who did not. As shown in
Table 3, patients in the experimental group and patients in
the control group showed similar characteristics before the
intervention.TABLE 3. Patients’ demographic and clinical data
Experimental Control
group* group{
n56 n44
Sex, M/F 30/26 19/25
Age, years
17–34 24 18
35–65 32 26
Years of asthma
510 22 20
410 34 24
Smoking habits
Smokers 9 5
Non-smokers 47 39
Atopia, skin testing +/7 44/12 31/13
Asthma severity
Mild 4 4
Moderate 31 29
Severe 21 11
*Self-management education programme using peak ex-
piratory flow monitoring.
{Self-management education programme based on symp-
toms only.
TABLE 4. Comparison of experimental and control groups bef
management education programme
Parameter Before interventio
EG (n56) CG (n44)
Days with symptoms* 73.2 70.4
Sleep disruptions 64.2 65.9
Asthma attacks 94.6 84
Absenteeism school/work 33.9 40.9
Visits to emergency ward 89.2 79.5
Hospital admission 30.3 22.7
Correct use of inhaler 57.1 43.1
FEV1 % predicted, mean (SD) 75.1 (3.2) 79.5 (3.5
FVC % predicted, mean (SD) 93 (3.1) 92 (3.6)
Adherence to treatment 44.6 29.6
EG: experimental group, self-management based peak expirato
CG: control group, self-management based on symptoms only
Data as percentage of patients except for FEV1 and FVC.
See text for definitions of morbidity parameters.Intergroup comparisons at the end of the study (Table 4)
showed that adherence to treatment was significantly higher
in the experimental group than in controls (83.4% of
patients as compared with 52.2%, P0.05). Mean FVC was
also higher among patients in the experimental group
(99.5+2.2% vs. 94.3+1.6%, P0.03).
Intragroup comparisons before and after participation in
the asthma self-management education programme,
showed statistically significant dierences (P50.05) in
diurnal symptoms, sleep disruptions, asthma attacks,
absenteeism, visits to the emergency room, hospital
admission, correct use of inhaler and adherence to
treatment in both groups. Mean FEV1 and FVC values
were significantly dierent among patients in the experi-
mental group, but among patients in the control group
dierences were not found (FEV1 79.5+3.5% before
intervention vs. 80.8+2.8% after intervention, P 0.32;
FVC 92+3.6% vs. 94.3+1.6, P 0.2).
In the multiple logistic regression analysis, independent
predictors of adherence to prescribed regimen were severity
of asthma (odds ratio 9.28, 95% confidence interval 1.87–
45.96, P 0.006 for moderate asthma) and type of self-
management education programme (odds ratio 6.19, 95%
confidence interval 2.04–18.81, P=0.001 for using peak
expiratory flow monitoring). Morbidity at enrolment and
improvement of asthma-related morbidity were not asso-
ciated with adherence.
When patients were stratified by severity of asthma, a
statistically significant association between adherence to
treatment and use of peak expiratory flow monitoring was
only found in the subset of patients with moderate asthma
(79%, 23/29 vs. 37%, 11/30; P 0.01) (Fig. 1). In patients
with severe asthma, adherence to treatment was recorded inore and after 12 months of participation in the asthma self-
n After intervention
P-value EG (n56) CG (n44) P-value
0.76 12.5 13.6 0.86
0.86 5.3 4.5
0.08 21.4 11.3 0.18
0.47 3.5 0
0.17 5.3 0
0.39 3.9 0
0.16 92.8 84.1
) 0.18 80.9 (2.3) 80.8 (2.8) 0.5
0.42 99.5 (2.2) 94.3 (1.6) 0.03
0.12 83.4 52.2 0.05
ry flow readings and symptoms.
.
FIG. 1. Adherence to prescribed regimens according to
severity of asthma. &: Experimental; &: control.
764 A. LO´PEZ-VIN˜A AND F. DEL CASTILLO-ARE´VALO95% (20/21) patients in the experimental group and in 91%
(10/11) in controls.
Discussion
The present results show that peak expiratory flow
monitoring in a context of optimal conditions, such as
optimized treatment, individualized self-management edu-
cation and regular follow-up, has a positive impact on
adherence to treatment and to a lower extent on functional
status in patients with asthma. Asthma-related morbidity
showed a marked improvement over the study period in
both groups of patients, which is consistent with findings of
other studies showing that adequate treatment, self-manage-
ment plans and regular follow-up are eective in improving
asthma outcomes, such as lung function, quality of life, use
of healthcare resources and asthma symptoms (9).
Although the benefits of asthma self-management
education programmes are well established, it is dicult
to determine which are the crucial components. It seems
that none of the individual elements (information or
instruction to acquire skills in self-management) would
have any eect on morbidity if they are not implemented
within the framework of a behaviour strategy. The current
debate is focused on whether self-management plans based
on peak expiratory flow monitoring should be added to
asthma education programmes as opposed to self-manage-
ment plans based on symptoms only (10–19). Eectiveness
of these approaches cannot be easily compared due to
dierences across studies, such as patients’ severity of
asthma, treatment during follow-up, presence and inter-
vention in the control group, etc. However, as pointed out
by Fishwick and Beasley (21) it may be reasonable
concluded that the greatest benefits from peak expiratory
flow monitoring would be obtained by patients with higher
risk of severe asthma attacks and poor self-perception of
symptoms, indicating that dierent patients have dierent
education needs.
Peak expiratory self-management plans have been
introduced with three aims: 1. to prevent asthma attacks
by the recognition and anticipation of functional impair-
ment, 2. to adjust treatment by measuring PEFR varia-
bility, and 3. to strength appropriate actions as a behaviour
strategy. In our study, it is dicult to ascertain the eect ofthe first objective given that after the second follow-up visit
symptoms had been properly controlled and there was no
need to handle asthma problems using self-management
plans. In agreement with results of Woolcock et al. (10),
improvement of adherence to medication and functional
status in patients in the experimental group is likely to be
associated with the influence of the other two purposes. It
may be postulated that more benefits can be obtained when
peak expiratory flow monitoring is integrated in a
behaviour-oriented strategy, so that by virtue of learning
how to take actions to handle asthma problems, patients
would perceive the use of peak flow meters as an
appropriate objective contributing to a behaviour change
and adherence to treatment (10,29–31). This would explain
an unexpected result of our study, that is, PEFR monitor-
ing was particularly beneficial in patients with moderate
asthma who probably found a strong reason for their
treatment in comparison with severe asthma patients who
already would have a high initial rate of motivation. Other
studies using behaviour methods (32,33) also showed
improvements in adherence to treatment, although it is
not possible to determine dierences in adherence accord-
ing to the degree of severity.
In accordance with the study of Cote et al. (18), the
higher degree of treatment adherence found in the
experimental group was not accompanied by a lower
asthma-related morbidity in comparison with controls.
This may be related to optimization of treatment for all
patients at the first visit resulting in early control of the
disease, so that dierences would only appear with a longer
follow-up period. However, a modest improvement in
functional status was found, which may indicate a better
control of the disease with a beneficial eect on prognosis
of asthma (10).
The present results, however, should be interpreted
taking into account a possible selection bias given that
33% of the patients enrolled in the study did not complete
the 12-month follow-up period, although statistically
significant dierences in baseline data between both groups
were not found. Studies of the eectiveness of self-
management plans in asthma patients have a number of
limitations (34), such as 1. unequal distribution of cases
assigned to the intervention and control groups—in the
present study, randomization prevented dierences, 2.
influence of factors that are dicult to analyse separately
(physician in charge, medication regimen, follow-up, type
of education, etc.), —in this study, peak expiratory flow
monitoring and self-management plans based on PEFR
readings was the only dierence between the two groups
(controls did not receive pamphlets that also included
information on PEFR), and patients were always visited by
the same pneumologist and nurse; and 3. the lack of
blinding,—in our study, patients were blinded but investi-
gators knew to which group patients had been assigned.
However, the absence of dierences in quantitative vari-
ables seems to indicate that results were not influenced by
this circumstance. It may be argued that the method used to
assess adherence (scales) overestimates adherence to
the prescribed regimen (35), although given that the
same instrument was used in all patients, potential
MONITORING OF PEAK EXPIRATORY FLOW 765overestimation of adherence to treatment would have been
equally distributed among participants.
We conclude that the use of peak expiratory flow
monitoring in optimal conditions (adequate medical regi-
men, individualized self-management education and regular
follow-up) showed a beneficial eect on adherence to
prescribed regimens in patients with moderate asthma.
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